Chuan-Yuan Li

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Duke University School of Medicine

Harvard University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Duke University School of Medicine

United States

Professor and Vice Chair for Research :: Dermatology

University of Colorado Denver School of Medicine

United States

Professor and Director, Division of Radiation and Cancer Biology :: Radiation Oncology

Duke University School of Medicine

United States

Assistant, Associate, and Full Professor :: Radiation Oncology

Education History

Harvard University

United States

PHD :: Cancer Biology

University of Science and Technology of China

China

BSC :: Chemistry

Publications

Chenchen Zhu, Fushun Fan, Chuan-Yuan Li, Yan Xiong, Xinjian Liu
Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation. Cell death & disease 15 (7) (2024)
Chenchen Zhu, Fushun Fan, Chuan-Yuan Li, Yan Xiong, Xinjian Liu
Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation. Cell death & disease 15 (7) (2024)
Meng Jiao, Christopher J Pirozzi, Chen Yu, Xuhui Bao, Mengjie Hu, Dong Pan, Sejiro Littleton, Nathan Reynolds, Daniel R Saban, Fang Li, Chuan-Yuan Li
Targeting Catechol-O-Methyltransferase Induces Mitochondrial Dysfunction and Enhances the Efficacy of Radiotherapy in Glioma. Cancer research (2024)
Chenchen Zhu, Fushun Fan, Chuan-Yuan Li, Yan Xiong, Xinjian Liu
Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation. Cell death & disease 15 (7) (2024)
Chenchen Zhu, Fushun Fan, Chuan-Yuan Li, Yan Xiong, Xinjian Liu
Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation. Cell death & disease 15 (7) (2024)
Meng Jiao, Xuhui Bao, Mengjie Hu, Dong Pan, Xinjian Liu, Jonathan Kim, Fang Li, Chuan-Yuan Li
VHL loss enables immune checkpoint blockade therapy by boosting type I interferon response. bioRxiv : the preprint server for biology (2023)
Dong Pan, Xuhui Bao, Mengjie Hu, Meng Jiao, Fang Li, Chuan-Yuan Li
SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy. Cancer research 82 (15) (2022)
Xuhui Bao, Xinjian Liu, Fang Li, Chuan-Yuan Li
Limited MOMP, ATM, and their roles in carcinogenesis and cancer treatment. Cell & bioscience 10 (2020)
Xinjian Liu, Xuhui Bao, Mengjie Hu, Hanman Chang, Meng Jiao, Jin Cheng, Liyi Xie, Qian Huang, Fang Li, Chuan-Yuan Li
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. Nature 588 (7839) (2020)
Schuyler Lee, Haolin Liu, Ryan Hill, Chunjing Chen, Xia Hong, Fran Crawford, Molly C Kingsley, Qianqian Zhang, Xinjian Liu, Zhongzhou Chen, Andreas Lengeling, Kathrin Maria Bernt, Philippa Marrack, John Kappler, Qiang Zhou, Chuan-Yuan Li, Yuhua Xue, Kirk Hansen, Gongyi Zhang
JMJD6 cleaves MePCE to release positive transcription elongation factor b (P-TEFb) in higher eukaryotes. eLife 9 (2020)
Min Zhou, Xinjian Liu, Zonghai Li, Qian Huang, Fang Li, Chuan-Yuan Li
Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells. International journal of cancer 143 (4) (2018)
Ian M Cartwright, Xinjian Liu, Min Zhou, Fang Li, Chuan-Yuan Li
Essential roles of Caspase-3 in facilitating Myc-induced genetic instability and carcinogenesis. eLife 6 (2017)

Chuan-Yuan Li.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Chuan-Yuan Li